FIELD: chemistry.
SUBSTANCE: invention relates to a xanthine derivative of formula (I),
formula (I),
where R is selected from 
;
R1 is selected from methoxycarbonyl; R2 is selected from hydrogen and halogen atoms; each of X and Y is independently selected from C or N; n equals 0, 1, 2, 3 or 4, for treating diseases associated with dipeptidyl peptidase IV.
EFFECT: disclosed is a xanthine derivative.
8 cl, 6 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| XANTHIC DERIVATIVE | 2013 |
|
RU2635109C2 |
| COMBINED THERAPY WITH GPR119 AGONISTS AND DPP-4 INHIBITORS | 2020 |
|
RU2818562C2 |
| CRYSTALLINE FORM A OF COMPOUND AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2699030C2 |
| DICYCLOAZAALKANE DERIVATIVES, METHODS FOR PRODUCTION THEREOF AND USE THEREOF IN MEDICINE | 2008 |
|
RU2487866C2 |
| AMINOTETRAHYDROPYRANES AS DIPEPTIDYLPEPTIDASE-IV INHIBITORS FOR TREATING OR PREVENTING DIABETES | 2010 |
|
RU2550508C2 |
| SUBSTITUTED AMINO SIX-MEMBER SATURATED HETEROALICYCLES AS LONG-ACTING DPP-IV INHIBITORS | 2016 |
|
RU2720488C2 |
| AZABICYCLOOCTANE DERIVATIVES, METHOD FOR PREPARING AND USING AS DIPEPTIDYL PEPTIDASE IV INHIBITORS | 2007 |
|
RU2447063C2 |
| TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVE SALTS, METHODS FOR PREPARING THEM AND MEDICAL APPLICATION THEREOF | 2010 |
|
RU2523543C2 |
| CRYSTAL FORM α OF COMPOUND OF MONOBENZOATE, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | 2015 |
|
RU2677660C2 |
| COMBINATION CONTAINING NEW DERIVATIVE 3-(4-(BENZYLOXY)PHENYL)HEX-4-IN-ACID AND OTHER ACTIVE INGREDIENT TO ACTIVATE G-PROTEIN 40 OF THE RECEPTOR ENZYME | 2015 |
|
RU2680248C1 |
